Brain scientists discover why adventure feels good
LONDON (Reuters) - Scientists have identified a primitive area of the brain that makes us adventurous -- a finding which may help explain why people routinely fall for "new" products when shopping.
Using brain scans to measure blood flow, British researchers discovered that a brain region known as the ventral striatum was more active when subjects chose unusual objects in controlled tests.
The ventral striatum is involved in processing rewards in the brain through the release of neurotransmitters like dopamine.
Scientists believe the existence of this age-old reward mechanism indicates there is an evolutionary advantage in sampling the unknown.
"Seeking new and unfamiliar experiences is a fundamental behavioral tendency in humans and animals. It makes sense to try new options as they may prove advantageous in the long run," said Bianca Wittmann of the Wellcome Trust Centre for Neuroimaging at University College London.
Being daring, however, also carries risks. Some choices could be dangerous and, in the modern world, selecting the new may, for instance, make consumers susceptible to marketing hype.
The positive feedback system in the brain could also contribute to some common vices.
"In humans, increased novelty-seeking may play a role in gambling and drug addiction, both of which are mediated by malfunctions in dopamine release," said Nathaniel Daw, now at New York University, who also worked on the study.
The findings were published online in the journal Neuron.
- Tweet this
- Share this
- Digg this
- In India, rice replaces ice in bucket challenge
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- UPDATE 3-Negative euro overnight rates show cracks in banking system
- Ukraine seeks to join NATO; defiant Putin compares Kiev to Nazis
- UPDATE 1-Don't mess with nuclear Russia, Putin says
Genetic studies of some of the earliest Ebola cases in Sierra Leone reveal more than 300 genetic changes in the virus as it leapt from person to person, changes that could blunt the effectiveness of diagnostic tests and experimental treatments now in development, researchers said on Thursday. Full Article